Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| LB Pharmaceuticals Inc(LBRX) | 0 | 1,149,240 | +1,149,240 | $0 | $44.11M | 6.34% | +$44.11M |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 667,000 | +667,000 | $0 | $40.02M | 5.75% | +$40.02M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 1,573,220 | +1,573,220 | $0 | $37.30M | 5.36% | +$37.30M |
| Obsidian Therapeutics Inc | 0 | 2,495,660 | +2,495,660 | $0 | $34.27M | 4.92% | +$34.27M |
| Immunocore Holdings plcADS(IMCR) | 0 | 1,063,234 | +1,063,234 | $0 | $32.21M | 4.63% | +$32.21M |
| 4d Molecular Therapeutics In | 0 | 2,227,917 | +2,227,917 | $0 | $31.88M | 4.58% | +$31.88M |
| Design Therapeutics Inc | 0 | 2,500,000 | +2,500,000 | $0 | $31.43M | 4.52% | +$31.43M |
| Cytokinetics, Incorporated(CYTK) | 0 | 470,000 | +470,000 | $0 | $30.98M | 4.45% | +$30.98M |
| First Tracks Biotherapeutics, Inc.(TRAX) | 0 | 814,000 | +814,000 | $0 | $28.85M | 4.15% | +$28.85M |
| Faeth Therapeutics Inc | 0 | 941,689 | +941,689 | $0 | $28.01M | 4.02% | +$28.01M |
| Tango Therapeutics, Inc.(TNGX) | 0 | 1,100,000 | +1,100,000 | $0 | $27.45M | 3.94% | +$27.45M |
| Neurogene Inc | 0 | 964,885 | +964,885 | $0 | $26.84M | 3.86% | +$26.84M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 765,000 | +765,000 | $0 | $24.79M | 3.56% | +$24.79M |
| Avalo Therapeutics Inc | 0 | 1,500,000 | +1,500,000 | $0 | $23.00M | 3.30% | +$23.00M |
| Contineum Therapeutics IncCL A | 0 | 1,693,694 | +1,693,694 | $0 | $22.73M | 3.27% | +$22.73M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 1,000,000 | +1,000,000 | $0 | $21.87M | 3.14% | +$21.87M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 1,680,000 | +1,680,000 | $0 | $19.66M | 2.82% | +$19.66M |
| Inhibikase Therapeutics Inc | 0 | 9,110,112 | +9,110,112 | $0 | $18.72M | 2.69% | +$18.72M |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 170,000 | +170,000 | $0 | $17.01M | 2.44% | +$17.01M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 400,000 | +400,000 | $0 | $14.88M | 2.14% | +$14.88M |
| Camp4 Therapeutics Corp | 0 | 3,625,576 | +3,625,576 | $0 | $14.65M | 2.10% | +$14.65M |
| Altimmune Inc | 0 | 4,230,000 | +4,230,000 | $0 | $12.10M | 1.74% | +$12.10M |
| Opus Genetics Inc | 0 | 2,411,657 | +2,411,657 | $0 | $11.67M | 1.68% | +$11.67M |
| Kailera Therapeutics, Inc.(KLRA) | 0 | 942,953 | +942,953 | $0 | $10.77M | 1.55% | +$10.77M |
| Sol-Gel Technologies LtdSHS NEW | 0 | 139,445 | +139,445 | $0 | $10.36M | 1.49% | +$10.36M |
| Inventiva SaADS | 0 | 2,657,997 | +2,657,997 | $0 | $9.81M | 1.41% | +$9.81M |
| Entrada Therapeutics Inc | 0 | 1,428,440 | +1,428,440 | $0 | $9.07M | 1.30% | +$9.07M |
| Aura Biosciences Inc | 0 | 1,443,333 | +1,443,333 | $0 | $9.06M | 1.30% | +$9.06M |
| Research Alliance Corp IiiCL A ORD SHS CL A | 0 | 822,500 | +822,500 | $0 | $8.91M | 1.28% | +$8.91M |
| X4 Pharmaceuticals Inc | 0 | 2,571,478 | +2,571,478 | $0 | $7.46M | 1.07% | +$7.46M |
| Century Therapeutics Inc | 0 | 4,134,969 | +4,134,969 | $0 | $7.07M | 1.02% | +$7.07M |
| Promis Neurosciences Inc | 0 | 557,103 | +557,103 | $0 | $6.04M | 0.87% | +$6.04M |
| Research Alliance Corp IvCL A | 0 | 500,000 | +500,000 | $0 | $6.00M | 0.86% | +$6.00M |
| Imagenebio Inc | 0 | 1,094,045 | +1,094,045 | $0 | $5.01M | 0.72% | +$5.01M |
| Minerva Neurosciences Inc | 0 | 1,419,000 | +1,419,000 | $0 | $4.75M | 0.68% | +$4.75M |
| Tcgx Acquisition CorpCL A | 0 | 250,000 | +250,000 | $0 | $3.13M | 0.45% | +$3.13M |
| Vtv Therapeutics IncCL A | 0 | 76,989 | +76,989 | $0 | $2.37M | 0.34% | +$2.37M |
| Onkure Therapeutics IncCL A | 0 | 619,557 | +619,557 | $0 | $1.69M | 0.24% | +$1.69M |